The North Sea’s Forties Pipeline System — one of the world’s most important crude oil conduits — resumed overnight after a short halt, coming on the heels of a more significant stoppage in December.
“The start-up of the Forties Pipeline System is now underway following the successful resolution of an issue on Feb. 7 with a feed control valve,” Ineos AG said in a statement.
The FPS is a key infrastructure link for North Sea, with Forties crude being one of the grades that derive the global oil benchmark Dated Brent. More than 80 fields feed into the system, which has flows of about 450,000 barrels a day when it’s operating normally. Those fields, including the Buzzard oil field, the U.K.’s largest, don’t have an outlet for their crude when the pipeline system shuts.
Brent crude spiked briefly yesterday on news of the pipeline’s halt. The benchmark grade dropped soon thereafter, closing 2 percent lower Wednesday, as the U.S. Energy Information Administration reported an increase in the nation’s crude stockpiles. Brent resumed its five-day slide Thursday, falling to $64.93 a barrel, near late-December levels, by 11:54 a.m. in London.
Hot Energy Stocks To Buy Right Now: KKR(KKR)
- [By Garrett Baldwin]
Let’s talk the top news in the marijuana industry today… including four stocks that could surge up to 1,000% during this election year.Here’s what you need to know…
The Top Stock Market Stories for Tuesday
Goldman Sachs Group Inc. (NYSE: GS) is leading a busy day of earnings reports on Tuesday. Shares are off 0.4% after the firm despite reporting a 40% year-over-year jump in profits and stronger-than-expected revenue. The firm reported earnings per share (EPS) of $5.98 on top of $9.40 billion in revenue. The Wall Street giant was expected to report EPS of $4.67 on top of $8.71 billion in revenue. The investment bank’s first six months of 2018 were its strongest in nine years. The stock slipped after the company announced that president David Solomon will be replacing CEO Lloyd Blankfein when he steps down from his role. Blankfein has been CEO for 12 years. It’s fair to say thatAmazon.com Inc. (Nasdaq: AMZN) went to the dogs on Monday. The company has extended its Prime Day promotion through 3 a.m. on Wednesday. The announcement came after the firm suffered significant outages during the start of the event on Monday afternoon. Rather than get access to deals, many customers were met with pictures of dogs, the firm’s standard error page. Finally, pay close attention to events on Capitol Hill on Tuesday. The U.S. House Judiciary Committee will question leaders of Alphabet Inc. (Nasdaq: GOOGL), Twitter Inc. (NYSE: TWTR), and Facebook Inc. (Nasdaq: FB) about how they store and filter user content. Last year, the Senate and House of Representatives slammed the companies for their roles in and responses to Russia’s interference in the 2016 election.
Three Stocks to Watch Today: CSX, NFLX, KKR
CSX Corp.(Nasdaq: CSX) will help lead today’s earnings calendar. Wall Street expects that the company will report EPS of $0.86 on top of $2.98 billion in revenue. Shares of Netflix Inc. (Nasdaq: NFLX) slipped after the firm’s user-growth estimates and quart
- [By WWW.GURUFOCUS.COM]
For the details of Jeff Ubben’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Jeff+Ubben
These are the top 5 holdings of Jeff UbbenTwenty-First Century Fox Inc (FOX) – 53,326,334 shares, 18.41% of the total portfolio. Alliance Data Systems Corp (ADS) – 5,877,400 shares, 15.07% of the total portfolio. CBRE Group Inc (CBG) – 24,916,923 shares, 10.92% of the total portfolio. Shares reduced by 13.72%KKR & Co LP (KKR) – 47,750,000 shares, 10.18% of the total portfolio. Shares added by 4.82%Morgan Stanley (MS) – 17,959,620 shares,
- [By ]
Kohlberg Kravis Roberts (KKR) : “I’m a buyer. I’ve respected them for generations. “
Mitek Systems (MITK) : “This one is too speculative for me. I’d buy NVIDIA (NVDA) .”
- [By Wayne Duggan]
On this day 39 years ago, KKR & Co. L.P. Unit (NYSE: KKR) completed the first modern leveraged buyout of a public company, taking over manufacturer Houdaille Industries for $355 million.
- [By Tim Melvin]
I’m talking about private equity behemoth KKR & Co. LP (NYSE: KKR) buying Envision Healthcare Corp. (NYSE: EVHC) for $5.7 billion in cash, with the total deal value adding up to $9.9 billion including debt. This marks one of the largest leveraged buyouts of 2018.
Hot Energy Stocks To Buy Right Now: Bayer Aktiengesellschaft (BAYRY)
- [By ]
Bayer AG (BAYRY) also rose 4.13% to 97.29 on reports that its mega-merger with Monsanto Co. (MON) would likely be approved by the Department of Justice. The Wall Street Journal reported that the companies have agreed additional asset sales.
- [By ]
Major competitive vendors that are developing treatments for pericarditis include:
Pfizer Inc. (PFE) Abbvie, Inc. (ABBV) XBiotech Inc. (XBIT) Handok AstraZeneca (AZN) Bayer AG (OTCPK:BAYRY) Reckitt Benckiser Group plc. (RB) PerkinElmer, Inc. (PKI) FUJIFILM Holdings Corporation (OTCPK:FUJIY) Merck Sharp & Dohme Corp. (MRK) ALLERGAN (AGN)
Concerning competitive advantage, management of the company is not aware of any therapies currently approved by the FDA for the treatment of recurrent pericarditis, the firms lead indication for rilonacept.
- [By Cory Renauer]
It looks like the benefit-to-risk ratio is off the charts for larotrectinib as well as LOXO-292, but the number of patients with TRK fusion cancers that fail multiple existing treatments is somewhere between 1,500 and 5,000 each year in the U.S. Investors also need to understand that Loxo Oncology licensed its candidates from Array Biopharma (NASDAQ:ARRY) and owes its partner substantial milestone payments and mid-single-digit royalties on any sales they might generate. Loxo has partnered withBayer AG (NASDAQOTH:BAYRY), and if approved, the German giant will share U.S. profits with Loxo and pay double-digit royalties on sales abroad.
- [By Todd Campbell]
Based on the company’s results, Bayer AG (NASDAQOTH:BAYRY) licensed the rights to larotrectinib in a nine-figure deal that included $400 million up front andup to $450 million in regulatory and first-sale milestones. The two companies will split profit in the United States. Outside the U.S.,Loxo Oncology will get tiered double-digit royalties based on sales levels, as well as up to $475 million in sales-based milestones.
Hot Energy Stocks To Buy Right Now: Wendy’s/Arby’s Group Inc.(WEN)
- [By Matt Hogan]
Growth within the industry is a bit lumpy, with limited-service restaurants, such as Wendys Co (NASDAQ: WEN) and Chipotle Mexican Grill, Inc (NYSE: CMG), growing at 5.3 percent in 2017 as compared to 3.5 percent for casual dining establishments according to the National Restaurant Industry.
- [By ]
In the Lightning Round, Cramer was bullish on Spirit AeroSystems (SPR) , Take-Two Interactive (TTWO) , Dunkin Brands (DNKN) and Wendy’s (WEN) .
Cramer was bearish on Bristol-Myers Squibb (BMY) and Univar (UNVR) .
- [By Jeremy Bowman]
The chart below shows how McDonald’s compares with some of its closest peers based on its valuation and expected growth rate.
Company P/E Ratio 2-Year Expected EPS Growth Rate
McDonald’s (NYSE:MCD) 26.2 23.6%
Starbucks (NASDAQ:SBUX) 26.2 27.3%
Wendy’s (NASDAQ:WEN) 21.8 58.1%
Restaurant Brands International(NYSE:QSR) 21.4 41.9%
Yum! Brands(NYSE:YUM) 23.2 29.7%
Data source: Yahoo! Finance. EPS = earnings per share.
- [By Stephan Byrd]
Cannae (NYSE: CNNE) and Wendys (NASDAQ:WEN) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, valuation, profitability, dividends, risk and analyst recommendations.
- [By Mac Greer]
Hestill has 29% of the company, he’s still plastered on the pizza boxes and the marketing –although, that’s really been pulled back. Then, it’s also come out this week that Wendy’s (NASDAQ:WEN)and Papa John’s,before all of this stuff came up over the past couple of months, they’reactually in talks to have some sort of merger. Going forward,if you’re the board of directors at Papa John’s,I think you have to really consider that possibility. Maybethe best step forward for the company is to look for a merger or a sale, because, man, this seems like a train wreck that keeps accelerating.Whenyou have Schnatter on the board, he would have to be in favor of a buyout or a merger for it to go through.